To The Moon

$Merck(MRK)$

$Merck & Co., Inc. (MRK) +2.36% Surge: Pharma Giant Nears 52-Week High, $132 Target in Sight 🎯

Latest Close Data: $MRK closed at $130.48 on July 24, 2026, up +2.36% (+$3.01). The stock is just 0.96% away from its 52-week high of $131.74. 📈

Core Market Drivers: The rally is fueled by positive sentiment following partner Kelun-Biotech’s encouraging Keytruda lung cancer trial results. Strong institutional backing from heavyweights like BlackRock (9.14% stake) and Vanguard provides a solid floor. Robust capital inflow of $2.73B today confirms active accumulation. 💊🧬

Technical Analysis: Momentum is building with a confirmed MACD Golden Cross (DIF: 1.89, DEA: 1.80). RSI(6) at 68.28 is approaching overbought territory, while RSI(12) at 61.95 confirms healthy bullish momentum. Volume hit 8.53M shares, and the KDJ J-line is spiking to 88.11, signaling strong short-term buying pressure but flagging potential for a pullback. 📊🔥

Key Price Levels: Primary support is $127.82 (today's low); Strong resistance is the 52-week high at $131.74. A break above this level, with volume, activates the next leg up toward the analyst mean target. 🚧

Valuation Perspective: With a TTM P/E of 36.49 and a Forward P/E of 44.24, MRK trades at a premium to its historical averages, pricing in high growth expectations from its oncology pipeline. The P/B ratio is 7.06. 🏦

Analyst Targets: Wall Street consensus is Strong Buy, with 28 analysts setting an average target of $132.45 (range: $100 - $155). This offers a modest 1.5% upside from the current price, suggesting the near-term optimism is largely priced in. 👨💼

Weekly Outlook: The chart points to a consolidation just below the $131.74 resistance. A weekly close above this pivot could target $135. Failure to hold $128 would see a retest of the $125 support zone. ⚠️

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice. Trading involves substantial risk of loss. ⚠️

🎯 $Merck & Co., Inc. (MRK) Options Strategy: Short Put Ladder (Neutral-to-Bullish High IV Crush)

• Underlying: MRK (Merck & Co., Inc.)

• View: Cautiously Bullish / Resistance Breakout Pending. The stock is consolidating near its 52-week high ($131.74) with strong momentum, but the high IV Rank (84%) suggests option premium is historically expensive. This strategy aims to capitalize on IV crush and a mild upward drift.

• Strategy Type: Advanced Neutral-to-Bullish / Volatility Selling.

• Option Contract Portfolio (Simulated):

  • Sell 1x MRK 08/21/2026 130.0 Put @ $2.04 (Bid: $1.91, Ask: $2.04)

  • Sell 1x MRK 08/21/2026 135.0 Put @ $5.20 (Bid: $5.20, Ask: $5.20)

  • Buy 1x MRK 08/21/2026 125.0 Put @ $0.53 (Bid: $0.32, Ask: $0.53)

• Max Gain & Loss:

  • Max Gain: $671 (Net credit received at entry, realized if MRK is above $135 at expiration).

  • Max Loss: Unlimited below the lower breakeven ($118.29). Loss profile is that of a short put.

• Initial Cost/Credit: $6.71 Credit (Net).